Picton Mahoney Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Picton Mahoney Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-400,474	Closed	-$15.8M	–	542
2023 Q2	$15.8M	Buy	+400,474	New	+$14.1M	0.68%	32
2022 Q3	–	Sell	-7,200	Closed	-$69K	–	854
2022 Q2	$69K	Buy	+7,200	New	+$90.4K	﹤0.01%	658

Picton Mahoney Asset Management's ISEE Position: Q3 2023 in Review

Picton Mahoney Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 400,474 shares — an estimated $15.8M sold.

Picton Mahoney Asset Management first reported a position in ISEE in Q2 2022 and held it in 2 quarters. The position peaked at $15.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Picton Mahoney Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Picton Mahoney Asset Management sold 400,474 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $15.8M.
Picton Mahoney Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
Picton Mahoney Asset Management's IVERIC bio, Inc. Common Stock position peaked at $15.8M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.